Cost-effectiveness of continuous versus intermittent chemotherapy for patients with HER2-negative advanced breast cancer
暂无分享,去创建一个
V. Tjan-Heijnen | F. Erdkamp | B. Ramaekers | M. Bos | J. Busschbach | A. K. M. Claessens | J. Bouma | A. E. van Leeuwen-Stok | A. K. Claessens